Clinical Pharmacokinetics of Gentamicin in Neonates
Gentamicin is a bactericidal aminoglycoside antibiotic, it inhibits the protein synthesis. Gentamicin is active against the majority of aerobic gram-negative bacilli such as Pseudomonas, Klebsiella and Escherichia coli. The gentamicin doses are 3 mg/kg once-daily for preterm newborns < 35 weeks o...
Main Author: | Gian Maria Pacifici |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2017-03-01
|
Series: | International Journal of Pediatrics |
Subjects: | |
Online Access: | http://ijp.mums.ac.ir/article_8365_44a262c6a0e188d2e410cf0c8eaf2505.pdf |
Similar Items
-
Clinical Pharmacology of Teicoplanin in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici
Published: (2016-10-01) -
Clinical Pharmacology of Fluconazole in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici
Published: (2016-03-01) -
Clinical Pharmacokinetics of Amikacin in Neonates
by: Gian Maria Pacifici, et al.
Published: (2017-02-01) -
Clinical Pharmacology of Ceftazidime in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici, et al.
Published: (2017-05-01) -
Clinical Pharmacology of Ampicillin in Neonates and Infants: Effects and Pharmacokinetics
by: Gian Maria Pacifici
Published: (2017-12-01)